Genmab A (GMAB) Notes Payables: 2018-2020
- Genmab A's Notes Payables rose 57.13% to $35,770 in Q4 2020 from the same period last year, while for Dec 2020 it was $35,770, marking a year-over-year increase of 57.13%. This contributed to the annual value of $35,770 for FY2020, which is 57.13% up from last year.
- Per Genmab A's latest filing, its Notes Payables stood at $35,770 for Q4 2020, which was down 100.00% from $8.1 billion recorded in Q2 2020.
- Over the past 5 years, Genmab A's Notes Payables peaked at $23.2 billion during Q2 2019, and registered a low of $22,765 during Q4 2019.
- In the last 3 years, Genmab A's Notes Payables had a median value of $8.1 billion in 2020 and averaged $10.0 billion.
- In the last 5 years, Genmab A's Notes Payables plummeted by 100.00% in 2019 and then spiked by 57.13% in 2020.
- Quarterly analysis of 3 years shows Genmab A's Notes Payables stood at $18.6 billion in 2018, then tumbled by 100.00% to $22,765 in 2019, then skyrocketed by 57.13% to $35,770 in 2020.
- Its Notes Payables was $35,770 in Q4 2020, compared to $8.1 billion in Q2 2020 and $22,765 in Q4 2019.
